Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Sodium glycolate |
EINECS | 220-624-9 |
CAS No. | 2836-32-0 | Density | 1.416 g/cm3 |
PSA | 60.36000 | LogP | -2.27140 |
Solubility | soluble in water | Melting Point |
210-218℃ |
Formula | C2H3NaO3 | Boiling Point | 265.6 °C at 760 mmHg |
Molecular Weight | 98.0338 | Flash Point | 128.7 °C |
Transport Information | N/A | Appearance | White to off-white powder |
Safety | 24/25 | Risk Codes | 36/37/38 |
Molecular Structure | Hazard Symbols | Xi | |
Synonyms |
Aceticacid, hydroxy-, monosodium salt (9CI);Glycolic acid, monosodium salt (8CI);Glycolic acid sodium salt;Hydroxyacetic acid sodium salt;Sodium glycolate; |
Article Data | 19 |
IUPAC Name: Sodium 2-hydroxyacetate
Synonyms of Sodium hydroxyacetate (CAS NO.2836-32-0): Acetic acid, hydroxy-, monosodium salt ; Glycolic acid, monosodium salt ; Glykokolan sodny ; Monosodium glycolate ; Sodium 2-hydroxyacetate ; Sodium lycolate
CAS NO: 2836-32-0
Molecular Formula: C2H3NaO3
Molecular Weight: 98.03
Molecular Structure:
EINECS: 220-624-9
H bond acceptors: 3
H bond donors: 2
Freely Rotating Bonds: 2
Polar Surface Area: 46.53 Å2
Flash Point: 128.7 °C
Enthalpy of Vaporization: 58.47 kJ/mol
Boiling Point: 265.6 °C at 760 mmHg
Vapour Pressure: 0.00125 mmHg at 25°C
Water Solubility: Soluble
Appearance: White to off-white powder
Product Categories of Sodium hydroxyacetate (CAS NO.2836-32-0): Pharmaceutical Intermediates
SMILES: [Na+].[O-]C(=O)CO
InChI: InChI=1/C2H4O3.Na/c3-1-2(4)5;/h3H,1H2,(H,4,5);/q;+1/p-1
InChIKey: VILMUCRZVVVJCA-REWHXWOFAZ
Std. InChI: InChI=1S/C2H4O3.Na/c3-1-2(4)5;/h3H,1H2,(H,4,5);/q;+1/p-1
Std. InChIKey: VILMUCRZVVVJCA-UHFFFAOYSA-M
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | intravenous | 1gm/kg (1000mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 306, 1942. |
cat | LDLo | oral | 500mg/kg (500mg/kg) | BEHAVIORAL: FOOD INTAKE (ANIMAL) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 306, 1942. |
mouse | LD50 | oral | 6700mg/kg (6700mg/kg) | LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL" KIDNEY, URETER, AND BLADDER: CHANGES PRIMARILY IN GLOMERULI BLOOD: CHANGES IN SPLEEN | Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 29(12), Pg. 53, 1985. |
rat | LD50 | oral | 7110mg/kg (7110mg/kg) | "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986Vol. -, Pg. 656, 1986. |
SODIUM HYDROXYACETATE is reported in EPA TSCA Inventory.
Safety Information about Sodium hydroxyacetate (CAS NO.2836-32-0):
Safety Statements: 24/25
S24/25: Avoid contact with skin and eyes.
RTECS: MC5525000
Mildly toxic by ingestion. When heated to decomposition it emits toxic fumes of Na2O.
General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media: Use carbon dioxide or dry chemical.
Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Use only in a chemical fume hood.
Storage: Store in a cool, dry place. Store in a tightly closed container.